Archive: December 17 2020

Find relevant news articles from other European projects, below:

CARAMBA  EURE-CART  CARAT Network ATECT PROCROP T2EVOLVE

Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:


vjhemonic6

UCART22 for R/R B-cell ALL

Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, presents the preliminary results of Balli-01 (NCT04150497), a Phase I study trialling the chimeric antigen receptor (CAR) T-cell therapy, UCART22, in adult patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL).

Visit website
vjhemonic15

Future directions for multiple myeloma treatment

  Dec 17 2020 Tagged MM, CAR-T

Thomas Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, gives an overview of the evolving treatment paradigm for multiple myeloma patients.

Visit website